文献速递乳腺乳腺X线

评估十年间对比增强乳腺摄影在中高危女性乳腺癌筛查中的应用

Evaluating ten years of breast cancer screening with contrast enhanced mammography in women with Intermediate-high risk.
PubMed 文献 · Eur J Radiol · 2024-10-28

该研究回顾性分析2012至2023年间一家三级中心5424例筛查性对比增强乳腺摄影(CEM)检查,中位年龄54.8±8.9岁,84.9%为致密乳腺。CEM检出74例乳腺癌,敏感度95.9%、特异度81.8%、AUC 0.923,癌检出率13.1/1000。作者认为CEM是致密乳腺女性可行的筛查方法,但需前瞻性研究评估长期预后影响。

要点

  • CEM筛查致密乳腺女性敏感度95.9%(71/74)、特异度81.8%(4378/5350)。
  • 癌检出率13.1/1000,AUC 0.923,阴性预测值99.9%(4378/4381)。
  • 阳性预测值仅6.8%(71/1043),提示活检阳性率偏低。

核心结论

  • CEM是致密乳腺女性可行的乳腺癌筛查方法,未来需前瞻性研究评估CEM筛查的长期预后影响。

研究设计与样本

  • 回顾性分析一家三级中心2012至2023年间所有筛查性CEM检查,共5424例,以活检结果和影像随访为参考标准。

诊断标准与关键数值

  • 以BI-RADS评分与活检及影像随访比较,CEM敏感度95.9%(71/74)、特异度81.8%(4378/5350)、阳性预测值6.8%(71/1043)、阴性预测值99.9%(4378/4381)、AUC 0.923、癌检出率13.1/1000。

临床应用与阅片要点

  • 作者认为CEM是致密乳腺女性可行的乳腺癌筛查方法,阅片时需注意其阳性预测值仅6.8%(71/1043)。

局限性

  • 原文为回顾性分析;作者指出未来需前瞻性研究评估CEM筛查的长期预后影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: While mammography is considered the gold standard for screening women for breast cancer, its accuracy declines in women with dense breasts. The purpose of the study is to evaluate the diagnostic accuracy of contrast enhanced mammography (CEM) for detecting breast cancer in intermediate and high-risk women, including those with genetic predispositions, over a decade-long cohort at a tertiary center.

METHODS: We retrospectively analyzed all CEM examinations performed for screening purposes at a tertiary center between 2012 and 2023. Data were extracted from imaging reports and from medical records. All biopsies performed up to one year following CEM examinations, and all breast cancer cases were extracted. BI-RADS scores from CEM reports were compared to biopsy results and to imaging follow-up. Sensitivity, specificity, positive and negative predictive values, area under the ROC curve (AUC), and cumulative cancer detection rate were calculated.

RESULTS: Overall 5,424 screening CEM examinations were analyzed. The mean age was 54.8 ± 8.9 years. Family history of breast cancer was recorded in 1,134/5,424 (20.9 %) women. Most women (4,606/5,424, 84.9 %) had dense breasts (BI-RADS C-D). Overall, 628 biopsies were performed within one year of screening, and 74 cancers were detected. CEM had sensitivity 95.9 % (71/74), specificity 81.8 % (4378/5350), positive predictive value 6.8 % (71/1043), negative predictive value 99.9 % (4378/4381). The cancer detection rate for CEM was 13.1 per 1,000 cases, and the AUC was 0.923.

CONCLUSIONS: CEM is a viable breast cancer screening method for women with dense breasts. Future prospective studies are needed to evaluate the long-term prognostic impact of CEM screening.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sorin V, Rahman N, Halabi N, et al. Evaluating ten years of breast cancer screening with contrast enhanced mammography in women with Intermediate-high risk. Eur J Radiol. 2024. PMID: 39509749. doi:10.1016/j.ejrad.2024.111807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。